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Abstract
Purpose To test a new 2-flash multifocal electroret-
inogram (mfERG) paradigm in glaucoma using a
reduced light intensity of the m-frame flash as opposed
to the global flash, as it has been suggested that this
may increase the responses induced by the global
flash, which has been the part of the mfERG response
where most changes have been noted in glaucoma.
Methods A mfERG was recorded from one eye of 22
primary open angle glaucoma (POAG) patients [16
normal tension glaucoma (NTG), 6 high tension
glaucoma (HTG)] and 20 control subjects. A binary
m-sequence (2^13-1, Lmax 100 cd/m
2, Lmin\1 cd/m
2),
followed by two global flashes (Lmax 200 cd/m
2) at an
interval of 26 ms (VERIS 6.0TM, FMSIII), was used.
The stimulus array consisted of 103 hexagons. Retinal
signals were amplified (gain = 50 K) and bandpass
filtered at 1–300 Hz. For each focal response, the root
mean square was calculated. We analyzed 5 larger
response averages (central 15 and 4 adjoining quad-
rants) as well as 8 smaller response averages (central
10 and 7 surrounding response averages of approx-
imately 7 radius each). Three epochs were analyzed:
the direct component at 15–45 ms (DC) and the
following two components induced by the effects of
the preceding focal flash on the response to the global
flashes at 45–75 ms (IC-1) and at 75–105 ms (IC-2).
Statistical analysis was performed using linear mixed
effects models adjusted for age.
Results Responses differed significantly between
POAG patients and controls in all central response
averages. This difference was larger for the central 10
than for the response average of the central 15. While
these observations held true for all response epochs
analyzed, the DC differed least and the IC-1 most
when POAG was compared to control. For POAG, the
most sensitive differential measure was IC-1 of the
central 10 with an area under the ROC curve of 0.78.
With a cutoff value of 12.52 nV/deg2, 80 % of the
POAG patients (100 % HTG, 69 % NTG) were
correctly classified as abnormal, while 77 % of the
control subjects were correctly classified as normal.
When the results of the mfERG were compared to the
visual fields, there was a tendency for the mfERG to
decrease as the mean defect increased. However, this
correlation was only significant in the superior nasal
quadrant when the IC-1 of the mfERG was compared
to the corresponding area of the visual field.
Conclusion When compared to findings from previ-
ous studies, reducing the luminance of the m-frame
flash in the 2-global flash paradigm did not increase
the sensitivity and specificity of the mfERG to detect
glaucoma further.
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Introduction
Glaucoma is one of the most frequent causes of visual
impairment and blindness worldwide. In the popula-
tion over 40 years old, 1 out of 40 people has
glaucoma. This means that 60 million people world-
wide are affected, and among these, 8.4 millions are
bilaterally blind [1]. The population is getting older, so
in the future the occurrence of problems caused by
glaucoma will increase.
The Early Manifest Glaucoma Trial (EMGT) has
suggested that a decrease of the IOP delays visual
impairment and therefore the course of disease [2].
Thus, irreversible blindness could be avoided by early
diagnosis and treatment. Analysis of different medical
databases shows that glaucoma screening of groups at
risk may even be cost-effective [3].
Glaucoma can be asymptomatic for a long period of
time. Early recognition of glaucoma therefore relies
on examinations. In the past, it was assumed that
structural loss precedes functional damage. Quigley
et al. postulated that an increased cup-to-disc ratio
precedes a detectable field loss. He demonstrated that
the disc glia are less susceptible to damage than axons,
which means that an early cup enlargement must then
represent nerve fiber loss [4]. It was thought that at
least 25–35 % nerve fiber loss is needed before an
abnormality in the visual field can be detected [5]. A
recent study by Hood et al. compared structural and
functional measures of glaucomatous damage by
comparing a functional test [standard automated
perimetry (SAP)] with a structural test [optical coher-
ence tomography (OCT)]. The relationship between
these two tests was described by a simple linear model.
The model predicted that both the SAP sensitivity and
the OCT thickness of the retinal nerve fiber layer
(RNFL) decrease linearly with retinal ganglion cell
loss. It predicted that the structural test (OCT) shows a
statistical significance in detecting glaucomatous
damage earlier than the functional test. However, if
the functional test reaches statistical significance first,
this patient was born with a thicker RNFL. Therefore,
he had a greater reserve of nerve fibers before the
RNFL dropped below the 5th percentile of normal due
to glaucomatous damage [6].
In an attempt to increase early detection of glau-
coma, where ganglion cell damage occurs, electroret-
inographical methods have been applied. Nearly
20 years ago, Sutter and Tran introduced the
multifocal electroretinogram (mfERG). This method
allows simultaneous but independent stimulation of
multiple retinal areas. Through cross-correlation,
individual electroretinographic responses are then
calculated from the overall response recorded, for
each stimulated retinal area. This allows an objective
topographic examination of retinal function with a
high resolution.
When the mfERG was applied in glaucoma,
conventional stimulation was not sensitive enough to
reliably detect early retinal dysfunction in glaucoma
[7–9]. Previous findings showed that interposing
bright global flashes into the stimulation sequence
increased the inner retinal contributions to the mfERG
and therefore its sensitivity in glaucoma. With the use
of 3 global flashes, the sensitivity to detect glauco-
matous dysfunction was 50 % [10]. One single global
flash increased the sensitivity to 75 % and the
specificity to 83 %. The most sensitive parameter
was the IC-1, the response induced by the effect of the
preceding bright and dark elements in the m-frame on
the response to the first global flash. Here, an
oscillation of the induced components (ICs) of the
temporal retina could be observed, which resulted in a
small nasal-temporal response asymmetry. This asym-
metry was significantly reduced in patients with
glaucoma due to a selective loss of this oscillatory
component in the temporal retina [11].
In another study using a 2-global flash mfERG,
90 % of the normal tension glaucoma (NTG) patients,
85 % of the high tension glaucoma (HTG) patients,
and 80 % of the control group were correctly classi-
fied. In that study, the binary bright and dark elements
in the m-frame (Lmax 200 cd/m
2 and Lmin \1 cd/m
2)
were followed by two global flashes with a brightness
of 200 cd/m2. Again, there was a significant difference
in the IC-1. Neither the response to the bright and dark
elements in the m-frame, the direct component (DC),
nor the response induced by the effect of the preceding
bright and dark elements in the m-frame on the
response to the second global flash (IC-2) differed
significantly between the groups examined [12].
Chu et al. modified a one-global flash paradigm to
examine the adaptive function of the retina: Localized
luminance differences between bright and dark ele-
ments of the m-frame were set at stimulus contrasts of
96, 65, 49, and 29 %. The peripheral IC showed a
linear dependence on the luminance difference, while
the peripheral DC was saturated at higher luminance
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differences. In glaucoma, amplitudes of the peripheral
DC were reduced at mid-luminance difference levels
and therefore did not reach saturation level as soon. An
adaptive index of the DC showed a good differenti-
ation between healthy subjects and glaucoma patients
with an area under the curve (AUC) of 0.986
(sensitivity: 93 %, specificity: 95 %) [13]. The total
recording time needed to obtain this data was
6 9 8 min which does not seem feasible in the clinic.
Chu et al. also showed that the IC-1 in glaucoma
differs most from control at high luminance differ-
ences, whereas the DC differs more at medium
luminance differences.
In the past, mfERGs have been obtained with a
conventional stimulus but at low contrast (7, 9). Here,
however, sensitivity of the response to the m-sequence
frame, the DC, was not sensitive enough to reliably
recognize early glaucomatous dysfunction.
A recent study by Shimada et al. [14] has confirmed
the importance of different luminance and contrast
behaviors on the DC and on the IC. With a focal flash
intensity of 100 cd/m2 and a global flash of 200 cd/m2,
the induced component is enhanced most, while the
DC is still discernible with a reasonable signal-to-
noise ratio. Inter-subject variability was largest in the
absence of a global flash. In the global flash paradigm,
inter-subject variability could be reduced with a lower
focal flash intensity. Thus, this study suggests that in a
global flash paradigm, reducing the light intensity of
the m-frame flash as opposed to the global flash may
increase the IC. In the present study, we therefore
applied these parameters in an attempt to increase this
inner retinal contribution and thus the sensitivity of the
mfERG to detect glaucomatous damage.
For the standard multifocal ERG, ISCEV recom-
mends a high pass cutoff between 3 and 10 Hz and low
pass cutoff between 100 and 300 Hz [15]. Previous
studies found significant differences between glau-
coma and control when the bandpass filter was set at
10–300 Hz [7]. Applying the same filter setting, the
sensitivity of the mfERG to detect glaucomatous
retinal dysfunction was increased when global flash
paradigms were introduced [10, 11].
In human glaucoma patients, a focal photopic
negative response ERG (PhNR ERG) recorded with
a low-frequency cutoff of 5 Hz showed significant
reduction of amplitude associated with a local
decrease in retinal sensitivity in POAG [16]. In
experimental glaucoma in macaques, a glaucoma-
sensitive low-frequency component (LFC) was iden-
tified under 25 Hz. Lou et al. [17] reported that the
low-frequency band can provide information on
retinal dysfunction in glaucoma in monkeys. This
suggests that in POAG, a filter setting of 1–300 Hz
might be more sensitive than a filter setting of
10–300 Hz.
Thus, compared to our previous ‘‘2-global flash’’
mfERG in glaucoma [12], the luminance of the focal
m-frame flash was reduced from 200 to 100 cd/m2. In
addition, the mfERG responses analyzed in this study
were recorded with a filter setting of 1–300 Hz in an
attempt to include low-frequency components and
thus increase the sensitivity of the mfERG to
glaucoma.
Methods
The adapted 2-global flash mfERG was obtained in
one eye of 22 patients (16 patients with NTG, 6
patients with HTG) and 20 control subjects. The study
was approved by the institutional review board of the
University of Basel. Informed consent was obtained
from patients and subjects after explanation of the
nature and possible consequences of the study.
For glaucoma patients, the following inclusion
criteria were applied:
1. A cup/disc ratio (CDR) of at least 0.5 with typical
glaucomatous changes, such as a localized thin-
ning of the neuro-retinal rim of the optic disc.
2. The presence of a glaucomatous visual field defect
with a mean defect (MD) C2.2 dB or a loss
variance (LV) C6 dB.
3. Before treatment with eye drops, a highest
measured intraocular pressure (IOP) above
21 mmHg in HTG patients, and an intraocular
pressure equal to or below 21 mmHg in NTG
patients.
For both glaucoma and control subjects, the
following exclusion criteria were applied:
The presence of systemic diseases such as hyper-
tension, diabetes mellitus, Parkinson’s disease or
depression treated with medication; other ocular
diseases such as refractive errors higher than 6
diopters of myopia or hyperopia, damage of the retina
caused by an arterial or venous occlusion, previous eye
surgery; eye diseases which decrease visual acuity,
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such as cataract or corneal damage. If possible, the
right eye was included, if it did not fulfill any
exclusion criteria.
MfERG recording
Patients were adapted to ambient room light for
30 min before mfERG testing. The pupil of the tested
eye was fully dilated (Tropicamide 0.5 %, Pheny-
lephrin 1 %). After cleaning the skin with Everi (spes
medica), a ground electrode was placed on the
forehead, with the Ten 20TM conductive EEG-paste
(Weaver and Company). To anesthetize the cornea,
Proparacaine 0.5 % and Tetracaine 1 % eye drops
were applied. Electrical responses were recorded
monocularly with a bipolar Burian-Allen contact lens
electrode (Hansen Ophthalmic Development Labs,
Iowa City, IA), which was wetted with the hydroxy-
propyl methylcellulose Methocel (OmniVision). The
other eye was occluded during the recording.
The mfERGs were recorded with VERIS Science
6.1.2TM (Visual Evoked Response Imaging System,
Electrodiagnostic Imaging, EDI). Refractive errors
were corrected by refracting for best visual acuity,
using the FMS III-fundus stimulator (EDI, San Mateo,
CA). During the recording, the central 50 of the retina
was stimulated with 103 hexagonal elements, which
were scaled with eccentricity in order to take into
account the retinal cone distribution. These hexagons
flickered between black and white according to
a binary m-sequence of 2^13-1 (Lmax 100 cd/m
2,
Lmin \1 cd/m
2), followed by two global flashes
(200 cd/m2) at an interval of 26 ms.
Retinal signals were amplified (gain = 50,000) and
bandpass filtered at 1–300 Hz. The total recording
time of 10 min and 55 s was divided into 16 segments.
An infrared camera, included in the device, allowed
monitoring of fixation during recording. Segments
with poor signal were stopped and re-recorded. The
artifact rejection technique, incorporated in the soft-
ware, was applied twice. Spatial filtering was not used.
Visual fields were obtained with the program G2 of
the Octopus perimeter (Octopus 101, HAAG STRE-
IT, Ko¨niz, Switzerland). The G2 is a threshold static
automated perimetry that includes 59 points within the
center from 0 to 30. The macula area is tested with a
resolution of 2.8. An additional 14 peripheral points
in the 30–60 area are screened as well. The stimulus
size is equivalent to the Goldmann III/3e stimulus.
Each stimulus is presented for 100 ms. The back-
ground luminance is 4 apostilb (asb).
Response analysis
Figure 1 depicts one stimulus base interval: an
m-frame (M), which can be light (100 cd/m2) or dark
(\1 cd/m2) is followed by two global flashes (F,
200 cd/m2) at an interval of 26 ms. For each focal
response, the root mean square (RMS) was calculated
for the following three epochs: the direct component at
15–45 ms (DC) and the following two response
components, which are induced by the effects of the
preceding focal flash on the response to the global
flashes at 45–75 ms (IC-1) and at 75–105 ms (IC-2).
The following two group averages were calculated
and compared between POAG and control subjects:
1. Five large response averages shown in Fig. 2
were analyzed. These include the central 15 and 4
adjoining quadrants. In glaucoma patients, these
quadrant averages were also correlated with the
corresponding visual field areas.
Fig. 1 The stimulus sequence (top) and its resulting overall
response (below). An m-frame (M) which can be a light focal
flash (100 cd/m2) or a dark frame (\1 cd/m2) is followed by two
global flashes (F) (200 cd/m2) at an interval of 26 ms. Thus, one
stimulus base interval consisted of the following sequence:
MBFBFB where B is a dark interposed frame (1 frame &
13.33 ms). The resulting response is shown below. It consists of
a response to the m-frame stimulus, the direct component (DC)
and two following induced components, induced by the effects
of the preceding focal flash on the response to the global flashes
at 45–75 ms (IC-1) and at 75–105 ms (IC-2)
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2. Eight smaller response averages depicted in
Fig. 3: the central 10 and 7 surrounding response
averages of approximately 14 diameter each. These
were additionally analyzed in order to not miss small
retinal dysfunctions caused by glaucomatous damage.
Statistical analysis
To predict the mfERG responses expressed as RMS
values, a linear mixed effects model was performed.
Fixed factors were disease status, location, epoch,
and age; subject was a random factor. Results are
expressed as differences of means with corresponding
95 % confidence intervals and p values.
To discriminate between POAG and control,
receiver operating characteristics (ROC) curves with
corresponding AUC (area under curve) values were
estimated for selected locations and epochs.
A p value \0.05 is considered significant. All
analyses were done using R version 2.12.0 [18].
Results
Table 1 shows the subjects’ clinical characteristics.
The control group included 7 men and 13 women,
aged 27–73 years [mean 51.4 (SD 14.7) years]. The
POAG group comprised 16 men and 6 women, aged
53–74 [mean 63.6 (SD 6.4) years]. Snellen visual
acuity was C0.8 in all participants and did not differ
significantly between the groups.
The mean IOP was slightly higher in the control
group [14.8 mmHg (SD 2.7)] than in the glaucoma
group [11.2 mmHg (SD 2.1)]. IOP did not differ
significantly between the NTG and the HTG group.
During the study, all participants had an IOP of
B20 mmHg.
The mean CDR was 0.27 (SD 0.1) in the control
group and 0.79 in the POAG group. Again, there was
no significant difference between NTG and HTG
group.
The mean absolute value of MD did not differ
between the NTG [6.13 dB (SD 4.07, median 4.2)] and
the HTG group [6.37 dB (SD 4.61, median 3.9)].
Table 2 depicts the difference of the means for the
responses from the 5 larger and 8 smaller group
averages (Figs. 2, 3) for control subjects and POAG
patients. Table 2 also summarizes these findings for
both HTG and NTG compared to control. As an
example, Fig. 4 illustrates the response averages for
glaucoma patients (right boxplots) compared to con-
trol (left boxplots) for the 5 larger response averages.
Fig. 2 The field view of the 5 large areas in which responses
were averaged to generate the 5 large response averages analyzed.
These include the central 15 (C) and the 4 adjoining quadrants:
ST superior temporal quadrant, SN superior nasal quadrant,
IT inferior temporal quadrant, IN inferior nasal quadrant
Fig. 3 The field view of the 8 smaller areas in which responses
were averaged to form smaller response averages, that is the
central 10 (C) and 7 surrounding response averages of
approximately 14: ST superior temporal area, S superior area,
SN superior nasal area, N nasal area, IT inferior temporal area,
I inferior area, IN inferior nasal area. These were also analyzed
in order to not miss small areas of retinal dysfunction caused
by glaucomatous damage. The temporal area in the field view,
that is, the nasal part of the retinal region, was excluded as it
contained the blind spot
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The top row presents IC-2, the middle row IC-1, and
the bottom row DC. The columns illustrate the
individual response averages.
Both control subjects and POAG had significantly
larger central than peripheral responses. This held true
for all response epochs analyzed. The biggest differ-
ence between patients and control subjects could be
seen in the central 15 where POAG differed signif-
icantly from control in all epochs examined. The
comparison of the peripheral large as well as the
peripheral small response averages did not show a
significant difference between patients and controls.
The difference between patients and control sub-
jects was larger in the central 10 than in the central
15. The IC-1 epoch differed most and the DC epoch
least, when POAG was compared to control. Even
though we only included 6 HTG patients, we tried to
also assess whether our results would differ if HTG
and NTG were looked at separately. HTG differed
more from the control group than NTG. Again, IC-1
differed most. In the central 10, all epochs examined
differed significantly from the control group, while in
the central 15 this only held true for the HTG group.
Here, NTG only differed significantly in the IC-1.
Figure 5 shows the area under the ROC curve for
the IC-1 epoch of the central 10, when POAG is
compared to the control group. An ROC provides the
ability of a test to differentiate between two groups.
The best sensitive discriminatory power for POAG
could be shown in the IC-1 of the central 10 with an
area under the ROC curve of 0.78. 80 % of the POAG
(100 % HTG, 69 % NTG) were correctly classified as
abnormal, while 77 % of the control subjects were
correctly classified as normal when a cutoff value of
12.52 nV/deg2 was used.
To assess the association between the MD of the
visual field and the mfERG, a linear regression was
performed. The responses of the mfERG measures were
converted to logarithmic scale. These values were then
compared to the corresponding quadrants of the visual
field. Results were calculated as regression slopes with
corresponding 95 % confidence intervals and p values.
There was a tendency for the mfERG to decrease as MD
increases. However, this was only statistically signif-
icant in the superior nasal quadrant when the IC-1 of the
mfERG was compared to the corresponding area of the
visual field. Results are not shown.
When compared to the results of a previous 2-global
flash paradigm [12], our results did not indicate a
higher sensitivity to detect glaucomatous damage. As
this might be due to patients being affected differently
by their glaucoma, we compared the visual field
Table 1 Describes the subjects parameters
Total f m
Control 20 13 7
POAG 22 6 16
NTG 16 6 10
HTG 6 0 6
Control POAG NTG HTG
VA (Snellen)
Mean 1.02 0.96 0.97 0.93
SD 0.09 0.10 0.10 0.10
Median 1.00 1.00 1.00 1.00
p value 0.07
logMAR
Mean -0.08 0.02 0.02 0.03
SD 0.25 0.05 0.04 0.05
median 0.00 0.00 0.00 0.00
p value 0.05
IOP (mmHg)
Mean 14.80 11.18 11.19 11.17
SD 2.28 2.48 2.10 3.54
Median 15.00 10.50 11.50 0.50
p value \0.001
CDR
Mean 0.27 0.79 0.80 0.76
SD 0.10 0.11 0.12 0.11
Median 0.80 0.80 0.75
p value \0.001
Age (years)
Mean 51.75 63.59 63.63 63.50
SD 14.77 6.35 5.8 8.12
Median 52.00 63.00 63.50 61.00
p value 0.02
MD (dB)
Mean 6.19 6.13 6.37
SD 4.11 4.07 4.61
Median 4.20 4.20 3.9
Within the POAG group, NTG did not differ significantly from
HTG. IOP was slightly higher in the control group. As
expected, the CDR was significantly smaller in the control
group. There was also a significant difference in age between
control and POAG subjects. This was taken into account during
the statistical analysis
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defects of the patients of the previous study of
Palmowski-Wolfe et al. [12] to those of the patients
in the present study. The overall MD of the present
study: median 4.2 (5–95 % CI 4.37–8.01) did not differ
from the MD of the previous study [12]: median 4.5,
(5–95 % CI 4.48–6.49). The MD shows a bigger
spread in the present study. We also compared the MD
of the corresponding quadrants and did not find a
difference between the studies (p = 0.84) (Table 3).
Discussion
Previous studies have shown that interposing bright
global flashes into the stimulation sequence increases
the inner retinal contributions to the mfERG and
therefore its sensitivity in glaucoma detection [10–12].
Typically, changes are seen in the response to the
global flashes.
Figure 1 shows that the mfERG response is derived
by adding the responses which follow a bright
m-frame flash and by subtracting those following a
dark m-frame. Therefore, a response to global flashes
(full-screen flashes) will only be visible in the derived
response if it is influenced differently by the response
to the preceding focal flash. This is the only stimulus
frame that differs in the individual stimulus base
intervals. Thus, the presence of a response to a global
flash—that is, an induced response component—
demonstrates the presence of retinal adaptation which
is presumed to be of inner retinal origin [12, 19].
In the present 2-global flash mfERG, the most
prominent difference was seen in IC-1 where POAG
differed significantly from control in the central 15
and even more in the central 10. This held true for
both NTG and HTG patients.
In glaucoma, the ganglion cells are primarily
affected. Glovinsky et al. studied the pattern of foveal
ganglion cell loss in glaucoma and observed that larger
ganglion cells show a selective loss in experimental
glaucoma in monkeys. These authors concluded that
testing the function of large foveal ganglion cells
would increase detection of early glaucoma damage.
The physiological variability of cell density is larger in
Table 2 The responses from the 5 larger and 8 smaller group averages (Figs. 2, 3) for control subjects and POAG patients also
separately for HTG and NTG compared to control
Epoch Comparison of the central area Group averages Difference of means ± 2 SEM p value
DC Glaucoma versus control 5 larger group averages -1.48 ± 1.16 0.01
IC-1 -2.50 ± 1.16 \0.001
IC-2 -1.89 ± 1.16 \0.001
DC 8 smaller group averages -2.46 ± 1.44 \0.001
IC-1 -4.77 ± 1.44 \0.001
IC-2 -3.77 ± 1.44 \0.001
DC HTG versus control 5 larger group averages -2.27 ± 1.62 0.01
NTG versus control -1.18 ± 1.22 0.05
IC-1 HTG versus control -4.47 ± 1.62 \0.001
NTG versus control -1.75 ± 1.22 \0.001
IC-2 HTG versus control -4.08 ± 1.62 \0.001
NTG versus control -1.06 ± 1.22 0.08
DC HTG versus control 8 smaller group averages -2.49 ± 2.06 0.02
NTG versus control -2.45 ± 1.52 \0.001
IC-1 HTG versus control -6.46 ± 2.06 \0.001
NTG versus control -4.13 ± 1.52 \0.001
IC-2 HTG versus control -6.87 ± 2.06 \0.001
NTG versus control -2.60 ± 1.52 \0.001
Averages are given in nV/deg2. Both control subjects and POAG had significantly larger central than peripheral responses. The
difference between PAOG and control was larger in the central 10 than in the central 15. This held true for all response epochs
analyzed. HTG differed more from the control group than NTG when they were looked at separately
The italicized numbers in the row of the p value highlight the comparisons which do not differ significantly
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the peripheral areas of the retina than in the central
ones. So tests for detecting glaucomatous damage may
be more precise if they involve the responses of the
ganglion cells of the central area which thus becomes
the area of maximum interest [20]. Interestingly, in our
study, the smaller central response averages appeared
to differ more between POAG and control than the
larger central response averages. This may reflect a
more focal glaucomatous damage in the patients that
may be lost if larger areas are averaged together.
Our finding of a significant central loss in the RMS
amplitudes of the DC, IC-1, and IC-2 of the 2-global
flash mfERG is in agreement with previous reports of
macular involvement in glaucoma [20–22]. It is also
consistent with previous OCT findings of macular
involvement in glaucoma, where a qualitative reduc-
tion in the thickness of the RGC layer by computer-
aided manual segmentation procedure corresponds to
local losses in visual field sensitivity [23].
When the results of the mfERG were compared
to the visual fields, we saw a tendency for the mfERG
to decrease as MD increased. However, this was
only significant in the superior nasal field (quadrant)
when the IC-1 of the mfERG was compared to the
corresponding area of the visual field. The significance
in the other areas may be impaired, as there is a wide
range of mfERG responses in the lower range of MD,
which is the range in which patients are expected to
have a more localized field defect.
In the POAG group, HTG patients differed more
from the control group than NTG patients. However,
both groups did not differ in MD (p = 0.87), cup/disc
ratio, or age. However, this needs to be viewed with
caution, as only 6 HTG patients were included
compared to 16 NTG patients.
For POAG, the best sensitive discriminatory power
could be shown in the IC-1 of the central 10 with an
area under the ROC curve of 0.78. With a cutoff value
Fig. 4 Glaucoma patients (right box plot) are compared to the
control group (left box plot) for the 5 larger response averages.
Each boxplot shows the following: first quartile (lower end of
box), median (point in box) and third quartile (upper end of box).
The whiskers represent the lowest data point (lower whisker)
still within 1.5 interquartile range (IQR) of the lower quartile
and the highest data point (upper whisker) still within 1.5 IQR of
the upper quartile. Outliers are shown as open rectangles. The
top row presents IC-2, the middle row IC-1 and the bottom row
DC. The columns illustrate the individual response averages:
C central 15, IN inferior nasal area, IT inferior temporal area,
SN superior nasal area, and ST superior temporal area. POAG
differed significantly from control in the central 15 in all
epochs examined
64 Doc Ophthalmol (2013) 126:57–67
123
of 12.52 nV/deg2, 80 % of the POAG (100 % HTG,
69 % NTG) were correctly classified as abnormal,
while 77 % of the control subjects were correctly
classified as normal.
While previously POAG only differed from control
in IC-1 [12], changing the luminance conditions of the
2-global flash paradigm revealed differences in all
epochs: the DC, the IC-1, and the IC-2. However,
when the IC-1, the most sensitive individual param-
eter, was analyzed in the central 10, the current
change in luminance conditions did not increase the
sensitivity and specificity of the mfERG to detect
glaucoma further.
This is not due to different stages of glaucoma,
because when the visual field MD defects for all
quadrants of both studies were compared, the POAG
patients of both studies did not differ significantly
(p = 0.84). However, these results may be influenced
by differences in distribution of more localized field
loss.
Two further differences exist between this study
and the previous one [12] that might influence the
results:
First, the differing stimulation characteristics of the
FM-III stimulator and the CRT (cathode ray tube)
monitor. The latter was used in our previous study
and also in the study of Shimada et al. [14] which
suggested the change in stimulus parameters. On the
other hand, this is unlikely to be relevant, as the
present study shows that when using an FMIII
stimulator, glaucomatous dysfunction can be observed
not only in the first induced component of the 2-global
flash mfERG, but also in DC and IC-2. As described in
the guidelines for clinical multifocal electroretinogra-
phy of ISCEV, CRT and LCD (liquid crystal display)
monitors differ from each other in the response time of
displays [15]. The FMSIII system applied in our study
uses a LCoS (liquid crystal on silicon) display which
may be compared to an LCD stimulator. The ampli-
tude and waveform of the mfERG can be affected by
these different modes of stimulation. Kaltwasser et al.
compared the suitability of a CRT and a LCD monitor
in the mfERG. The pixel of a CRT monitor lights up
with a very high intensity directly at the beginning of a
frame. After 2–3 ms, luminance decays and remains
dark until the next stimulus frame. In an LCD monitor,
the liquid crystals need time to align themselves in a
new orientation in the cell’s electric fields. Therefore,
in an LCD monitor, the pixel lights up slowly with a
delay of 2–10 ms and luminance remains constant for
the remaining frame length. At the end of the frame,
light emission is slowly decreased to zero. The most
Fig. 5 The receiver operating characteristics (ROC) curve for
the IC-1 epoch of the central 10, when POAG was compared to
the control group. An ROC gives information about sensitivity
and specificity of a test and thus provides the ability of a test to
differentiate between two groups. The best sensitive discrimi-
natory power for POAG could be shown in the IC-1 of the
central 10 with an area under the ROC curve of 0.78
Table 3 Comparing the
MD (in dB) of the
corresponding quadrants
of the visual fields of the
present to the previous
study [12]
There is no significant
difference between them
(p = 0.84)
MD ST MD SN MD IN MD IT
Median
Present study 4.95 6.50 2.45 2.75
Previous study 4.85 4.55 3.25 3.75
95 % CI
Present study 4.25–8.26 5.27–10.70 3.27–9.14 2.14–6.41
Previous study 5.00–8.24 4.60–8.32 3.63–6.45 2.96–4.79
p value 0.76 0.90 0.46 0.51
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important observation in this study was an increase in
N1 and P1 latencies while using the LCD monitor.
Thus, a good mfERG response can be recorded with
either stimulator, but because of the differences in
the resulting responses, the reader needs to know
which stimulation device was used [24]. As we do not
compare mfERGs across studies, it is unlikely that the
different stimulator used at present would greatly
influence the difference in sensitivity to glaucoma
observed.
Second, the different filter setting which was
1–300 Hz in the present study, but 10–300 Hz in the
previous study [12]. A recent study has shown a
glaucoma sensitive response in the lower frequencies
of the 2-flash mfERG, the LFC [17]. Therefore, we
changed the filter setting as described above.
In conclusion, reducing the luminance of the
m-frame flash to 100 cd/m2 in the 2-global flash
paradigm and lowering the high pass filter to 1 Hz did
not increase the sensitivity and specificity of the
mfERG to detect glaucoma further, when compared to
findings from previous studies.
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